Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
Reduction in HbA1c at 104 weeks greater with exenatide plus dapagliflozin versus either drug alone
Read More »Drug Combo Offers Long-Term Glycemic Control in T2DM
Restricting Symptoms at the End of Life Decreasing
Decreases seen for difficulty sleeping; chest pain or tightness; shortness of breath; cold or flu symptoms; and nausea, vomiting, or diarrhea
Read More »ASN: Finerenone May Slow Progression in CKD With T2DM
Risks for chronic kidney disease progression, CV events lower with finerenone versus placebo
Read More »Green Tea, Coffee Intake Linked to Reduced Mortality in T2DM
Higher levels of consumption of green tea and/or coffee may reduce mortality in those with T2DM
Read More »Maternal Hypothyroidism Linked to Risk for ADHD in Offspring
Risk for ADHD increased in children of mothers with hypothyroidism diagnosed prior to, during pregnancy
Read More »Outcomes Worse for Women With MI at 50 Years or Younger
Women less likely to undergo coronary revascularization, receive guideline-directed medical treatment
Read More »Ertugliflozin Noninferior for CV Outcomes in T2DM With ASCVD
Ertugliflozin is noninferior to placebo for the primary end point of major adverse cardiovascular events
Read More »Sitagliptin May Cut Mortality in T2DM Patients With COVID-19
Sitagliptin at time of hospitalization linked to reduced mortality, improved clinical outcomes
Read More »FDA Warns Companies About Illegal Sales of Dietary Supplements
The supplements contain cesium chloride, but no cesium chloride-containing products are FDA-approved
Read More »DKA Episode May Harm Cognitive Function in Children With T1D
Lower IQ and worse memory seen in children with newly diagnosed type 1 diabetes and single event
Read More »